Explore more publications!

Tech Daily Dominican Republic: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Dominican Republic.

Press releases published on March 27, 2026

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
Estate Software Wins Prestigious AI Award
Scytale Expands SOX ITGC Compliance Capabilities Following AudITech Acquisition
Xtra Atto Gains Attention as a Wearable 4K POV Camera Priced at $299
VIRTUNE AB (PUBL) PUBLISHES ANNUAL REPORT FOR THE FINANCIAL YEAR 2025
VIRTUNE AB (PUBL) OFFENTLIGGÖR ÅRSREDOVISNING FÖR RÄKENSKAPSÅRET 2025
First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder
Maris-Tech Receives Order to Conduct Situational Awareness Pilot on Armored Vehicle in the United States
ASUS Republic of Gamers Announces New Zephyrus Lineup in Canada, Led by the Flagship Zephyrus Duo
Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026
Crusoe Announces New 900 MW AI Factory Campus in Abilene, Texas to Support Microsoft AI Infrastructure
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
Earth Month 2026: 42% of travelers say they take steps to travel more responsibly, according to Holafly
VERSES® Announces Closing of Second Tranche of Private Placement Offering of Units
Axe Compute to Host Annual Report Conference Call
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC
Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions